Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis

OBJECTIVE: The objective of this meta-analysis was to compare the efficacy and drug safety of tolvaptan with placebo for autosomal dominant polycystic kidney disease (ADPKD). METHODS: The PubMed, Embase, and Cochrane Library databases were searched from inception to September 10, 2021. Eligible stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jingkui, Xu, Wei, Gong, Lifeng, Xu, Min, Tang, Weigang, Jiang, Wei, Xie, Fengyan, Ding, Liping, Qian, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Nephrology - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958178/
https://www.ncbi.nlm.nih.gov/pubmed/36069961
http://dx.doi.org/10.1007/s11255-022-03353-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958178/
https://www.ncbi.nlm.nih.gov/pubmed/36069961
http://dx.doi.org/10.1007/s11255-022-03353-8

Ejemplares similares